CHAPTER 107 TRAUMA OUTCOMES
All surgeons who care for patients with injury are subject to increased scrutiny relative to the outcomes of their patients. In fact, all participatory physicians, nurses, technicians, hospitals, and state trauma systems should have a heightened interest in trauma outcomes. Not only does outcome analysis provide a platform for performance improvement and patient safety, but may have a significant impact on liability, cost, and reimbursement. As pay-for-performance initiatives emerge, the survival of trauma centers and systems may be at risk.
OUTCOMES
Outcomes may be viewed differently from the perspective of the patient, provider, payer, and society. The standard outcome parameters are outlined in Table 1. Although survival (live/die) seems straightforward, the endpoint in time may vary considerably, including in hospital, 30 days, 6 months, 1 year, and time to death. These variations project imprecision into many of the existing severity scoring and mortality prediction models.
EVIDENCE-BASED MEDICINE
The discipline of evidence-based medicine has emerged over the past decade to allow investigators to quantify the power of scientific studies based on the certainty of the scientific methods employed. Although simplistic, a classification system has been well received by the medical community that allows dialog among investigators (Table 2). Fortunately, the trend of dominance of class III data in the world of trauma outcomes is slowly giving way to significant class II and class I outcome studies in trauma and critical care.
Evidence | Description |
---|---|
Class I | Prospective, randomized, controlled trials—the gold standard of clinical trials. However, some may be poorly designed, lack sufficient patient numbers, or suffer from other methodological inadequacies. |
Class II | Clinical studies in which the data were collected prospectively; retrospective analyses based on clearly reliable data. Types of study so classified include observational studies, cohort studies, prevalence studies, and case–control studies. |
Class III | Most studies based on retrospectively collected data. Evidence used in this class indicates clinical series, databases, registries, case reviews, case reports, and expert opinion. |
Technology assessment | The assessment of technology, such as devices for monitoring intracranial pressure, does not lend itself to classification in the format above. Thus, for technology assessment, devices were evaluated in terms of accuracy, reliability, therapeutic potential, and cost effectiveness. |
In general, class I and class II studies provide the fuel for the strongest evidence-based guidelines on which to base the processes of trauma care (Table 3). The value of class III studies is to point the researcher toward an area of need and to help formulate the appropriate null hypothesis for a higher-power study. However, there are many clinical questions that have prohibitive barriers that prevent class I and class II studies, thereby augmenting the value of class III evidence.
< div class='tao-gold-member'> Only gold members can continue reading. Log In or Register a > to continue
Stay updated, free articles. Join our Telegram channelFull access? Get Clinical TreeGet Clinical Tree app for offline access |